Cloning, sequencing, and demonstration of polymorphism in trypanothione reductase from Crithidia fasciculata.
Trypanothione reductase (TR) is a target for drug design since it is unique to trypanosomatids, substituting for the otherwise ubiquitous enzyme, glutathione reductase. We report the cloning and sequencing of several cDNAs and genes encoding Crithidia fasciculata TR, the structure of which has recently been solved by crystallography. Single base polymorphisms are detected in cDNAs (containing 80% of the coding sequence) and two different genomic clones, including a glutamine to glutamate change in the C-terminal region of the TR coding region; other nucleotide changes are silent. Homology (from genomic clones, both of which contained signals appropriate for expression) to the Trypanosoma congolense gene was 63% at the nucleic acid level, with 68% amino acid identity; the significance of homologies to human and Escherichia coli glutathione reductase sequences is discussed. Polymorphic sites in the genomic clones included sites found in the cDNAs, indicating that differences existing in the genomic sequence are real, and propagated to RNA.
Field
H
H
Laboratory of Medical Biochemistry, Rockefeller University, New York 10021.
Cerami
A
A
Henderson
G B
GB
D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D015139:Blotting, Southern; D003001:Cloning, Molecular; D016831:Crithidia fasciculata / Q000235:genetics*; D016054:DNA, Protozoan; D008969:Molecular Sequence Data; D009247:NADH, NADPH Oxidoreductases / Q000235:genetics* / Q000378:metabolism; D011110:Polymorphism, Genetic; D012689:Sequence Homology, Nucleic Acid
D016054:DNA, Protozoan; D009247:NADH, NADPH Oxidoreductases; C049608:trypanothione reductase